Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial

Salwender, Hans; Weinhold, Niels; Benner, Axel; Miah, Kaya; Merz, Maximilian; Haenel, Mathias; Jehn, Christian; Mai, Elias; Menis, Ekaterina; Blau, Igor; Scheid, Christof; Hose, Dirk; Seckinger, Anja; Luntz, Steffen; Besemer, Britta; Munder, Markus; Brossart, Peter; Glass, Bertram; Lindemann, Hans-Walter; Weisel, Katja; Hanoun, Christine; Schnitzler, Paul; Klemm, Sarah; Goldschmidt, Hartmut; Raab, Marc; Elmaagacli, Ahmet

Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial

Autor(en):

Salwender, Hans; Weinhold, Niels; Benner, Axel; Miah, Kaya; Merz, Maximilian; Haenel, Mathias; Jehn, Christian; Mai, Elias; Menis, Ekaterina; Blau, Igor; Scheid, Christof; Hose, Dirk; Seckinger, Anja; Luntz, Steffen; Besemer, Britta; Munder, Markus; Brossart, Peter; Glass, Bertram; Lindemann, Hans-Walter; Weisel, Katja; Hanoun, Christine; Schnitzler, Paul; Klemm, Sarah; Goldschmidt, Hartmut; Raab, Marc; Elmaagacli, Ahmet

Tübinger Autor(en):

Besemer, Britta

Erschienen in:

Hematology (2024), Bd. 29, H. 1

Verlagsangabe:

Abingdon : Taylor & Francis Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1080/16078454.2024.2320006

ISSN:

1024-5332